The study by Yu et al. combined both approaches, while demonstrating simultaneous knockout of CXCR4 and CCR5 using an LV containing Cas9 and sgRNAs to obtain resistance to both R5- and X4-tropic HIV-1 infection in susceptible cell lines without any off-target mutations. This evidence concerns the gene CCR5 and HIV-1 infection.